FDA’s Approval of New Alzheimer’s Drug is Real, But Very Modest, Advance
The drug, Leqembi, does not reverse symptoms. In patients in the early stages of Alzheimer's disease, it slowed cognitive and functional decline somewhat compared with placebo. The FDA’s approval of Leqembi is not the end of the Alzheimer’s journey, but it could be a way station.
